We provide the latest news
from the world of economics and finance
(RTTNews) - Shares of diabetes care company Embecta Corp. (EMBC) are falling more than 12 percent Friday morning after the company provided full-year profit outlook below the Street view.
Embecta now expects adjusted profit in the range of $1.95 - $2.15 for the full year. Analysts on average, polled by Thomson-Reuters expects the company to report earnings of $2.22 per share.
Revenue for the full year is expected in the range of $1.094 billion - $1.116 billion. This compares with the consensus estimate of $1.1 billion for the year.
EMBC is at $15.48 currently. It has traded in the range of $12.72 - $33.88 in the last 1 year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.